Farshid Dayyani is an expert in the field of Oncology. Farshid Dayyani is also published. He has 27 publications published. The lastest publication: "Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).' He accepts all Medicare patients.
NPI NUMBER | 1376710434 | |
NPPES Provider LastName | DAYYANI | |
NPPES Provider FirstName | FARSHID | |
NPPES Provider ZIPCode | 852342165 | |
NPPES Provider State | AZ | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 365.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 22.0 | |
Percent Opioid Claims | 6.03 |
National Provider Identifier [NPI] | 1376710434 |
Last Name Of The Provider | DAYYANI |
First Name Of The Provider | FARSHID |
View All |
Dr. Edgardo C. Rivera, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Puneet Bhalla, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Santosh K. Rao, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Wishwdeep S. Dhillon, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Klaus W. Wagner, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sumeet K. Mendonca, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jade Homsi, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Madappa N. Kundranda, MD
This Doctor is OpenDoctor Recommended. |